Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2007

01-02-2007

Results of an Aggressive Approach to Resection of Locally Recurrent Rectal Cancer

Authors: Bryan J. Wells, Peter Stotland, Michael A. Ko, Wigdan Al-Sukhni, Jay Wunder, Peter Ferguson, Joan Lipa, Linda Last, Andrew J. Smith, Carol J. Swallow

Published in: Annals of Surgical Oncology | Issue 2/2007

Login to get access

Abstract

Background

The value of resection for locally recurrent rectal cancer (LRRC) remains controversial. We analyzed outcomes of an aggressive approach to resection of LRRC.

Methods

We conducted a retrospective chart review of 52 consecutive patients who underwent resection of LRRC from September 1997 through August 2005. Overall and disease-free survival (OS, DFS) curves were constructed by the Kaplan–Meier method, and compared by log-rank analysis. Median follow-up time was 29 months (range 3–72).

Results

Thirty-one patients (60%) were male. Median age was 60 years (range 36–88). Forty-six of the 52 patients were resected with curative intent, while 6 had known distant metastases at the time of resection. All 52 patients underwent grossly complete resection of local disease, and 41 (79%) had microscopically clear resection margins. An en bloc sacrectomy was performed in 28 (54%) patients. Postoperative mortality was nil; significant complications developed in 42% of patients. The complication rate was higher in patients with sacrectomy than without (50 vs. 33%, P = 0.017, Chi square). For the entire cohort of 52 patients, median OS and DFS were 40 and 24 months, respectively. Survival was equivalent in patients with and without sacrectomy. In the 46 patients who had resection with curative intent, 4-year OS was 48%. Median OS in the six patients with distant metastases at the time of resection was 21 months. OS was predicted by the presence of metastases (P = 0.01), and margin status (P < 0.0001). DFS was predicted by margin status (P = 0.0001).

Conclusions

In this series of patients who underwent resection of LRRC, microscopic margin status was the most significant predictor of OS and DFS. Requirement for en bloc sacrectomy was not associated with inferior survival. Carefully selected patients with distant metastases may benefit from resection of LRRC.
Literature
1.
go back to reference Nelson H, Sargent DJ. Refining multimodal therapy for rectal cancer. N Engl J Med 2001; 345:690–2PubMedCrossRef Nelson H, Sargent DJ. Refining multimodal therapy for rectal cancer. N Engl J Med 2001; 345:690–2PubMedCrossRef
2.
go back to reference Kapiteijn E, Marijnene CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345:638–46PubMedCrossRef Kapiteijn E, Marijnene CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345:638–46PubMedCrossRef
3.
go back to reference Lingareddy V, Ahmad NR, Mohiuddin M. Palliative reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1997; 38:785–90PubMedCrossRef Lingareddy V, Ahmad NR, Mohiuddin M. Palliative reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1997; 38:785–90PubMedCrossRef
4.
go back to reference Wong R, Thomas G, Cummings B, Froud P, et al. The role of radiotherapy in the management of pelvic recurrence of rectal cancer. Can J Oncol 1996; 6(Suppl 1):39–47PubMed Wong R, Thomas G, Cummings B, Froud P, et al. The role of radiotherapy in the management of pelvic recurrence of rectal cancer. Can J Oncol 1996; 6(Suppl 1):39–47PubMed
5.
go back to reference Wong CS, Cummings BJ, Brierley JD, et al. Treatment of locally recurrent rectal carcinoma—results and prognostic factors. Int J Radiat Oncol Biol Phys 1998; 40:427–35PubMed Wong CS, Cummings BJ, Brierley JD, et al. Treatment of locally recurrent rectal carcinoma—results and prognostic factors. Int J Radiat Oncol Biol Phys 1998; 40:427–35PubMed
6.
go back to reference Esnaola NF, Cantor SB, Johnson ML, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 2002; 20:4361–67PubMedCrossRef Esnaola NF, Cantor SB, Johnson ML, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 2002; 20:4361–67PubMedCrossRef
7.
go back to reference Wright FC, Crooks D, Fitch M, et al. Qualitative assessment of patient experiences related to extended pelvic resection for rectal cancer. J Surg Oncol 2005;00:1–8 Wright FC, Crooks D, Fitch M, et al. Qualitative assessment of patient experiences related to extended pelvic resection for rectal cancer. J Surg Oncol 2005;00:1–8
8.
go back to reference Takagi H, Morimoto T, Hara S, et al. Seven cases of pelvic exenteration combined with sacral resection for locally recurrent rectal cancer. J Surg Oncol 1986; 32:184–8PubMedCrossRef Takagi H, Morimoto T, Hara S, et al. Seven cases of pelvic exenteration combined with sacral resection for locally recurrent rectal cancer. J Surg Oncol 1986; 32:184–8PubMedCrossRef
9.
go back to reference Pearlman NW, Donohue RE, Stiegmann GV, et al. Pelvic and sacropelvic exenteration for locally advanced or recurrent anorectal cancer. Arch Surg 1987; 122:537–41PubMed Pearlman NW, Donohue RE, Stiegmann GV, et al. Pelvic and sacropelvic exenteration for locally advanced or recurrent anorectal cancer. Arch Surg 1987; 122:537–41PubMed
10.
11.
go back to reference Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002; 45:585–92PubMedCrossRef Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002; 45:585–92PubMedCrossRef
12.
go back to reference Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003; 237:502–8PubMedCrossRef Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003; 237:502–8PubMedCrossRef
13.
go back to reference Garcia-Aguilar J, Cromwell JW, Marra C, et al. Treatment of locally recurrent rectal cancer. Dis Colon Rectum 2001; 44:1743–8PubMedCrossRef Garcia-Aguilar J, Cromwell JW, Marra C, et al. Treatment of locally recurrent rectal cancer. Dis Colon Rectum 2001; 44:1743–8PubMedCrossRef
14.
go back to reference Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005; 48:929–37PubMedCrossRef Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005; 48:929–37PubMedCrossRef
15.
go back to reference Bedrosian I, Giacco G, Pederson L, et al. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 2005; 49:1–8 Bedrosian I, Giacco G, Pederson L, et al. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 2005; 49:1–8
16.
go back to reference Fong Y, Fortner F, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309–18PubMedCrossRef Fong Y, Fortner F, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309–18PubMedCrossRef
17.
go back to reference Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999; 189:291–9PubMedCrossRef Iwatsuki S, Dvorchik I, Madariaga JR, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999; 189:291–9PubMedCrossRef
18.
go back to reference McCormack PM, Ginsberg RJ. Current management of colorectal metastases to lung. Chest Surg Clin N Am 1998; 8:119–26PubMed McCormack PM, Ginsberg RJ. Current management of colorectal metastases to lung. Chest Surg Clin N Am 1998; 8:119–26PubMed
19.
go back to reference Tepper JE, O’Connell M, Hollis D, et al. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from intergroup study 0114. J Clin Oncol 2003; 21:3623–28PubMedCrossRef Tepper JE, O’Connell M, Hollis D, et al. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from intergroup study 0114. J Clin Oncol 2003; 21:3623–28PubMedCrossRef
20.
go back to reference Wiig JN, Tveit KM, Poulsen JP, et al. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002; 62:207–13PubMedCrossRef Wiig JN, Tveit KM, Poulsen JP, et al. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002; 62:207–13PubMedCrossRef
21.
go back to reference Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93:583–96PubMedCrossRef Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93:583–96PubMedCrossRef
22.
go back to reference Tjandra JJ, Kilkenny JW, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2005; 48:411–23PubMedCrossRef Tjandra JJ, Kilkenny JW, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2005; 48:411–23PubMedCrossRef
23.
go back to reference Camilleri-Brennan J, Steele RJC. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 2001; 27:349–53PubMedCrossRef Camilleri-Brennan J, Steele RJC. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 2001; 27:349–53PubMedCrossRef
24.
go back to reference Miner TJ, Jaques DP, Shriver CD. A prospective evaluation of patients undergoing surgery for the palliation of an advanced malignancy. Ann Surg Oncol 2002; 9:696–703PubMedCrossRef Miner TJ, Jaques DP, Shriver CD. A prospective evaluation of patients undergoing surgery for the palliation of an advanced malignancy. Ann Surg Oncol 2002; 9:696–703PubMedCrossRef
25.
go back to reference Yamada K, Ishizawa T, Niwa K, et al. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001; 88:988–93PubMedCrossRef Yamada K, Ishizawa T, Niwa K, et al. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001; 88:988–93PubMedCrossRef
Metadata
Title
Results of an Aggressive Approach to Resection of Locally Recurrent Rectal Cancer
Authors
Bryan J. Wells
Peter Stotland
Michael A. Ko
Wigdan Al-Sukhni
Jay Wunder
Peter Ferguson
Joan Lipa
Linda Last
Andrew J. Smith
Carol J. Swallow
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9119-4

Other articles of this Issue 2/2007

Annals of Surgical Oncology 2/2007 Go to the issue